AGC Biologics, a global Biopharmaceutical CDMO, completed the facility expansion for its new plasmid DNA (pDNA) and messenger RNA (mRNA) production line at its Heidelberg, Germany site.   With this expansion and added production line, AGC Biologics can now offer more plasmid material in high-quality and GMP grades and expand the services it offers for mRNA supply. The addition to the Heidelberg facility uses state-of-the-art single-use equipment, creating the flexibility to produce different p...